Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

Hemcheck Sweden

Less than 1K followers
All
Press releases
ShowingAll content types
Regulatory press release11/13/2024, 2:15 PM

Bio Vitos Pharma AB (publ) appoints LAGO KAPITAL as liquidity provider

Hemcheck Sweden
Regulatory press release2/12/2024, 12:50 PM

Bio Vitos Pharma AB: KFUM Kalmar and Bio Vitos Pharma enter into an agreement regarding a research study on Succifer

Hemcheck Sweden
Regulatory press release12/20/2023, 6:30 AM

Bio Vitos Pharma AB: The European Patent Office EPO grants patent that is important to Bio Vitos Pharma

Hemcheck Sweden

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Regulatory press release10/20/2023, 2:20 PM

Hemcheck completes the transaction with Bio Vitos

Hemcheck Sweden
Regulatory press release5/15/2023, 1:20 PM

Hemcheck has received a first order from its distributor Astemed

Hemcheck Sweden
Regulatory press release5/4/2023, 12:00 PM

Hemcheck submits a formal application to Nasdaq for a decision on continued listing before the implementation of the Bio Vitos agreement

Hemcheck Sweden
Regulatory press release4/26/2023, 2:20 PM

Hemcheck: Additional follow up order from the Foundation for Innovative New Diagnostics (FIND)

Hemcheck Sweden
Regulatory press release4/5/2023, 8:50 PM

Hemcheck has received a first order from the university hospital Charité in Berlin

Hemcheck Sweden
Regulatory press release3/16/2023, 12:10 PM

Hemcheck: Additional agreement with Bio Vitos Medical brings forward the time for calling the extraordinary general meeting by one week

Hemcheck Sweden
Regulatory press release3/13/2023, 4:00 PM

Hemcheck has received a first follow up order from its Finnish distributor

Hemcheck Sweden
Regulatory press release3/2/2023, 4:00 PM

Hemcheck has received an additional follow up order from its UK distributor

Hemcheck Sweden
Regulatory press release2/28/2023, 8:15 PM

Hemcheck receives follow up order from research program in the United States

Hemcheck Sweden
Regulatory press release2/3/2023, 3:30 PM

Hemcheck has received a follow up order from its French distributor

Hemcheck Sweden
Regulatory press release2/1/2023, 1:30 PM

Hemcheck has received a follow up order from its UK distributor

Hemcheck Sweden
Regulatory press release1/24/2023, 4:00 PM

Hemcheck has received a first order from a leading hospital in Iceland

Hemcheck Sweden
Regulatory press release1/23/2023, 10:00 AM

Hemcheck has received a follow up order from its Spanish distributor

Hemcheck Sweden
Regulatory press release1/16/2023, 9:30 PM

Hemcheck has received another follow up order from its Irish distributor

Hemcheck Sweden
Regulatory press release1/3/2023, 4:27 PM

Hemcheck extends agreement regarding previously communicated project with Region Skåne

Hemcheck Sweden
Regulatory press release12/20/2022, 9:00 AM

Hemcheck has received a follow up order from its Irish distributor

Hemcheck Sweden
Regulatory press release12/12/2022, 2:00 PM

Hemcheck has received an important order from a major OEM

Hemcheck Sweden
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.